Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway.
about
The endocannabinoid system as an emerging target of pharmacotherapyModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionPresynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?The role of CB1 receptors in psychostimulant addictionInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionEndogenous opiates and behavior: 2006Endocannabinoid signalling in reward and addiction.Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies.Neural basis for a heritable phenotype: differences in the effects of apomorphine on startle gating and ventral pallidal GABA efflux in male Sprague-Dawley and Long-Evans rats.Mice expressing a "hyper-sensitive" form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumption.Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens Shell.Dissociable roles of mGlu5 and dopamine receptors in the rewarding and sensitizing properties of morphine and cocaine.Enhanced Extracellular Glutamate and Dopamine in the Ventral Pallidum of Alcohol-Preferring AA and Alcohol-Avoiding ANA Rats after MorphineDifferential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.Neural Circuit in the Dorsal Raphe Nucleus Responsible for Cannabinoid-Mediated Increases in 5-HT Efflux in the Nucleus Accumbens of the Rat BrainEndocannabinoid system involvement in brain reward processes related to drug abuseEffects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait.Hedonic hot spots in the brain.The endocannabinoid system in brain reward processesA neuropeptide-centric view of psychostimulant addictionMicrodialysis and the neurochemistry of addiction.Ventral pallidum roles in reward and motivation.Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout miceNon-opioid antinociception produced by brain stem injections of improgan: significance of local, but not cross-regional, cannabinoid mechanisms.Role of endocannabinoids in regulating drug dependence.The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.Advances in the field of cannabinoid--opioid cross-talk.Neurotensin in the ventral pallidum increases extracellular gamma-aminobutyric acid and differentially affects cue- and cocaine-primed reinstatement.Hypothesis-driven medication discovery for the treatment of psychostimulant addictionA role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditionsRimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala.Candidate genes for cannabis use disorders: findings, challenges and directionsPreclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg.Bivalent ligands that target μ opioid (MOP) and cannabinoid1 (CB1) receptors are potent analgesics devoid of tolerance.Regional Influence of Cannabinoid CB1 Receptors in the Regulation of Ethanol Self-Administration by Wistar Rats.Preclinical evidence of new opioid modulators for the treatment of addiction.New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds.Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling.Endocannabinoid signaling in neurotoxicity and neuroprotection.
P2860
Q24648473-D23D0BA0-D9C2-4C0B-9FD4-D9A1A1F4CC8DQ27014154-D2FA4970-067A-4FA7-AF67-9FFC2F03F473Q28078759-6E9AE337-F8AA-4A91-876A-6BF4BDC6CE46Q28280265-A72FA538-FBAB-437F-96B4-50AF84BE3104Q28283718-052EDC3D-F737-4FEF-A1E0-F7855F52D1ACQ28752585-21911A0E-72C9-41EA-A68F-E1D52BA4F1AFQ30373359-EBB39CDC-DE0E-4000-8380-D60BCF36B98FQ30471663-F4D972F7-37EF-4F16-94CC-D9E0C5AD6F4FQ30485495-784C4E7E-4E6A-4A25-AD2E-AAFD8A60E6A6Q33585822-CBC3A452-2746-433B-8655-888A60E32E27Q34359778-9360CDB3-68FA-49FD-92E3-152847307C91Q34714448-CED47DE2-4217-4D73-831A-3C6569D2D3DEQ34985814-4010AFFC-EC0D-45B1-8EFA-FDC16978AB6BQ35193322-503A297F-1402-45DE-AFFA-2E87F6B13EAFQ35532072-53789670-A66B-4166-9DED-4AEA84585853Q36102335-6E42D20A-E867-4967-8DA2-C4723D89705AQ36357182-0E5B8426-0CE8-4822-90AE-82AC216618DFQ36529112-AF2F9E96-B0D1-4F82-9FCB-5A29624E9533Q36641847-F4CE498B-8B65-42DC-977C-0E06CC532E2DQ36741861-C8B6E581-FC29-4ADC-A0F7-FE71B895AD10Q36741898-013A8F36-1673-4899-90BA-C251AB56E09CQ36967426-DEF41030-F073-45CC-BD2E-FF876A1CDB91Q37023219-F9B089CB-15B0-4BA0-9CC1-F90C0FB22080Q37060812-CAD44C1D-7C35-4F8C-98BA-4D622BD223DBQ37111714-92C5DD4A-91BD-4F0F-B53B-204F63A28F1CQ37129779-7FE03F97-1BD3-487E-A832-9C295FF9810CQ37142233-B1060196-E18D-4373-A901-17CFABC77A6BQ37164808-4D6F6D5E-2769-44F7-91AF-4DCEFDD6B13BQ37168720-AB190FCF-910E-4FF3-BD62-590A4EA32B4EQ37183687-A885EF88-CC7A-446D-8FB5-5CDA2F37C15BQ37208086-CD9DA43E-FC81-40CC-B416-344A6089F539Q37235843-89B41862-7B7F-4FB7-AD3B-7D2F3A0CFD6EQ37245382-89D461C7-9DFB-418B-908B-ABE9DAF36AF1Q37356740-DD87FFCC-AEC8-4D84-82B4-FFEB263B1B49Q37360643-68349F39-C37E-495A-8FC7-2626C10CDA06Q37495511-C499E760-0896-4AD5-ADB5-8DAC053E828BQ37772519-E4BBE2B1-0987-4B38-8BCD-10FE4FFFC0E0Q38395251-7FBD1B9D-5FE0-4108-884D-4E949649381CQ39400299-0A03952F-1B5B-40E6-8B80-9D9071919E3AQ41386290-FD69AC51-AB16-455A-B846-E45366586031
P2860
Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Cannabinoid modulation of opia ...... ntral striatopallidal pathway.
@en
Cannabinoid modulation of opia ...... ntral striatopallidal pathway.
@nl
type
label
Cannabinoid modulation of opia ...... ntral striatopallidal pathway.
@en
Cannabinoid modulation of opia ...... ntral striatopallidal pathway.
@nl
prefLabel
Cannabinoid modulation of opia ...... ntral striatopallidal pathway.
@en
Cannabinoid modulation of opia ...... ntral striatopallidal pathway.
@nl
P2860
P356
P1476
Cannabinoid modulation of opia ...... entral striatopallidal pathway
@en
P2093
Loren H Parsons
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300848
P407
P577
2006-04-01T00:00:00Z